Logo image
Sign in
JAAD Game Changer: "High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa"
Journal article   Peer reviewed

JAAD Game Changer: "High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa"

Andrew Patterson
Journal of the American Academy of Dermatology, Vol.90(1), pp.90-90
01/01/2024
PMID: 37595889

Abstract

Dermatology Life Sciences & Biomedicine Science & Technology

Metrics

1 Record Views

Details

Logo image